1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Cue Health Inc.

Cue Health Inc.

HLTHQ
Cue Health Inc.US flagOther OTC
0.00
USD
- -
- -
1,591.00Market Cap
Cue Health Inc.
HLTHQ
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
TTM
FRC
0.05
0.12
11.66
3.2
0.42
0.26
Revenue per Share
-0.16
-0.37
1.64
-1.31
-2.44
-1.8
Basic EPS, GAAP
-0.12
0.13
-2.24
-1.1
-0.96
-0.58
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.49
-0.86
-0.45
-1.47
-3.87
- -
Book Value per Share
-0.45
-0.81
13.24
3.78
1.51
- -
Tangible Book Value per Share
128
128
53
148
153
155
Basic Weighted Avg Shares
7
15
616
474
64
40
Sales/Revenue/Turnover
-313.42
-293.2
30.89
-42.95
-429.4
-472.7
Operating Margin (%)
4
6
33
49
56
44
Depreciation Expense
-21
-47
86
-194
-373
-279
Net Income, GAAP
- -
- -
27.49
- -
- -
- -
Effective Tax Rate (%)
-310.99
-307.66
14.03
-40.93
-581.51
-702.93
Profit Margin (%)
11
28
503
300
67
- -
Working Capital
4
12
50
45
42
- -
LT Debt
-58
-101
707
576
250
- -
Total Equity
- -
- -
39.83
- -
- -
- -
Return on Invested Capital (%)
- -
- -
-339.24
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
ST Debt
7
6
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
43
42
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
155
155
- -
Market Capitalization
67
25
29

Working Capital

FRC

•

in mil. unless spec.
Sep'23
Dec'23
Mar'24
Total Current Assets
192
110
- -
Cash, Cash Equivalents & STI
111
81
- -
Accounts Receivable, Net
1
1
- -
Inventories
64
14
- -
Total Current Liabilities
58
43
- -
Payables & Accruals
48
34
- -
ST Debt
7
6
- -
Deferred Revenue
1
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-56.59%
Free Cash Flow
- -
- -
-9.33%
Net Income, GAAP
- -
- -
92.45%
Sales/Revenue/Turnover
- -
- -
-86.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
177
84
67
146
474
2023
24
8
15
17
64
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
0.02
-0.67
-0.45
-0.21
-1.31
2023
-0.62
-0.55
-0.31
- -
-2.44
2024
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Similar Companies
Ningbo David Medical Device Co., Ltd. (300314.SZ)
Polarean Imaging plc (PLLWF)
Bionovate Technologies Corp (BIIO)
Adherium Limited (ADR.AX)
Holdco Nuvo Group D.G Ltd. Warrants (NUVOW)
DVx Inc. (3079.T)
Business
Cue Health Inc. previously operated as a healthcare technology firm, dedicated to delivering accessible and individualized diagnostic capabilities to both consumers and medical professionals. The company's core offering, the Cue Health platform, enabled access to lab-standard diagnostic tests in various settings, including at-home and point-of-care, complemented by on-demand virtual consultations and treatment pathways for diverse health and wellness requirements. Its comprehensive Cue Integrated Care platform was comprised of several key elements: a hardware component known as the Cue Health Monitoring System, which featured a portable, reusable Cue Reader, specialized single-use Cue Cartridges, and a Cue Wand for sample collection; a software solution called the Cue Data and Innovation Layer, offering cloud-based data management and analytical tools; Cue Virtual Care Delivery Applications, encompassing the Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations, designed for connectivity with electronic medical record systems, pharmacies, last-mile delivery services, clinician networks, and laboratories. Initially, a significant part of its business revolved around COVID-19 testing kits, with plans for broader diagnostic applications. Founded in 2010 and headquartered in San Diego, California, the company was initially known as Cue Inc. before adopting the name Cue Health Inc. in December 2017. However, facing significant challenges, including a heavy reliance on COVID-19 testing and an inability to pivot post-pandemic, Cue Health Inc., along with its affiliated entities, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware on May 28, 2024. This action followed the cessation of its operations and the layoff of its remaining workforce and executive team. Prior to the bankruptcy, the company had also received a warning from the Nasdaq regarding non-compliance, indicating an expected delisting of its common stock.